Posted in Other 30+ days ago.
Location: Cambridge, Massachusetts
The Role:
Moderna is seeking a self-motivated and adaptable Sr. Research Associatewith strong experience in developing virology assays to support the development of novel vaccines and therapeutics. The candidate will support preclinical and clinical programs through the development and execution of virological assays, and interface with internal as well as external partners and collaborators. This position will contribute to the Infectious Diseases (ID) therapeutic area through the performance and development of laboratory-based assays for both mechanistic and quantitative assessment of novel therapies. The individual will work with scientists within ID and other parts of the company to ensure the highest level of quality of these assays.
Here's What You'll Do:
Work closely with scientists to develop and execute assays related to vaccine development
Culture diverse mammalian cell lines and primary cells
Execute assays including virus neutralization and ELISA assays
Interpret, summarize experimental data and maintain excellent laboratory note books
Here's What You'll Bring to the Table:
B.S. with 3+ years of relevant experience in virology, immunology or related discipline.
Extensive experience with cell and tissue culture using sterile technique is required.
Knowledge and hands-on experience in virus culture and characterization (e.g. TCID50, plaque assay, virus replication, virus neutralization, cell viability) is highly preferred.
Proficiency or familiarity in molecular biology, PCR/qPCR, cloning, western blotting, flow cytometry, and ELISA is preferred.
Attention to detail, ability to multi-task, and strong communication skills
Excellent record keeping and data management skills
Familiarity with GraphPad Prism is a plus
Here's What We'll Bring to the Table:
Candidates should be aware that Moderna currently maintains a policy requiring all US-based employees to be fully vaccinated against COVID-19. Newly hired employees must be vaccinated prior to their employment start date. Moderna is an equal opportunity employer and will provide a reasonable accommodation to those unable to be vaccinated where it is not an undue hardship to the company to do so as provided under federal, state, and local law.
About Moderna:
In 10 years since its inception, Moderna has transformed from a science research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across six modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for both clinical and commercial production at scale and at unprecedented speed. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. Most recently, Moderna's capabilities have come together to allow the authorized use of one of the earliest and most effective vaccines against the COVID-19 pandemic.
Moderna's mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and auto-immune diseases. Moderna has been named a top biopharmaceutical employer by Science for the past six years. To learn more, visit www.modernatx.com.
Moderna is a smoke-free, alcohol-free and drug-free work environment.
Moderna is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law. Moderna will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
#LI-AM1-
American Cybersystems, Inc.
|
Thermo Fisher Scientific
|
Thermo Fisher Scientific
|